American Communications Enterprises Inc Sample Contracts

AutoNDA by SimpleDocs
ESCROW AGREEMENT
Escrow Agreement • June 8th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • New Jersey
RECITALS:
Shareholder Agreement • November 19th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
GUARANTY --------
Guaranty • May 20th, 2003 • Neogenomics Inc • Services-commercial physical & biological research • Florida
RECITALS
Consulting Agreement • November 19th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
NeoGenomics, Inc. (a Nevada corporation)
Underwriting Agreement • January 11th, 2021 • Neogenomics Inc • Services-testing laboratories • New York

NeoGenomics, Inc., a Nevada corporation (the “Company”), confirms its agreement with BofA Securities, Inc. (“BofA Securities”), Morgan Stanley & Co. LLC (“Morgan Stanley”) and Goldman Sachs & Co. LLC (“Goldman Sachs”), as representatives (the “Representatives”) of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth on Schedule A hereto of $300,000,000 aggregate principal amount of the Company’s 0.25% Convertible Senior Notes due 2028 (“Initial Securities”) and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase, solely to cover over-allotments, all or any part of an additional $45,000,000 aggregate pr

RECITALS --------
Loan and Security Agreement • May 20th, 2003 • Neogenomics Inc • Services-commercial physical & biological research • Florida
BACKGROUND
Registration Rights Agreement • March 30th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • Nevada
NEOGENOMICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 4, 2020 1.25% Convertible Senior Notes due 2025
Indenture • May 4th, 2020 • Neogenomics Inc • Services-testing laboratories • New York

INDENTURE, dated as of May 4, 2020, between NEOGENOMICS, INC., a Nevada corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 7th, 2008 • Neogenomics Inc • Services-testing laboratories • Nevada

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of November 5, 2008, by and between NEOGENOMICS, INC., a Nevada corporation, (the "Company"), and FUSION CAPITAL FUND II, LLC (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").

NEOGENOMICS, INC. PLACEMENT AGENT AGREEMENT
Placement Agent Agreement • June 8th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • Florida
RECITALS --------
Loan Agreement • May 20th, 2003 • Neogenomics Inc • Services-commercial physical & biological research • Florida
NEOGENOMICS, INC. Common Stock, par value $0.001 per share Underwriting Agreement
Underwriting Agreement • August 15th, 2014 • Neogenomics Inc • Services-testing laboratories • New York

NeoGenomics, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 7,000,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,050,000 additional shares (the “Optional Securities”) of common stock, par value $0.001 per share (“Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).

AutoNDA by SimpleDocs
LETTER OF INTENT BY AND BETWEEN AMERICAN COMMUNICATIONS ENTERPRISES, INC. And AEROGROUP INCORPORATED
Letter of Intent • August 20th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • May 15th, 2007 • Neogenomics Inc • Services-testing laboratories • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2007, between Power3 Medical Products, Inc., a New York corporation (the “Company”), and NeoGenomics, Inc. a Nevada Corporation, (the “Purchaser”).

EXHIBIT 4 EMPLOYMENT CONTRACT OF ROBERT E. RINGLE
Employment Contract • February 10th, 1999 • American Communications Enterprises Inc
RECITALS
Loan Agreement • March 30th, 2005 • Neogenomics Inc • Services-commercial physical & biological research • Florida
RECITALS:
Employee Stock Option Agreement • November 19th, 2001 • American Communications Enterprises Inc • Radio & tv broadcasting & communications equipment • Florida
—] Shares1 NeoGenomics, Inc. Common Stock, par value $0.001 per share PURCHASE AGREEMENT
Purchase Agreement • February 28th, 2013 • Neogenomics Inc • Services-testing laboratories • New York

NeoGenomics, Inc., a Nevada corporation (the “Company”), and the stockholder of the Company listed in Schedule I hereto (the “Selling Stockholder”) severally propose to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of [—] shares (the “Firm Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The Firm Shares consist of [—] authorized but unissued shares of Common Stock to be issued and sold by the Company and [—] outstanding shares of Common Stock to be sold by the Selling Stockholder. The Company also has granted to the several Underwriters an option to purchase up to [—] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”

INVESTOR REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 6th, 2007 • Neogenomics Inc • Services-testing laboratories • Nevada

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May ___, 2007, by and among NEOGENOMICS, INC., a Nevada corporation (the “Company”), and [NAME OF INVESTOR], a ___________ _____ (the “Investor”).

CREDIT AGREEMENT by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, NEOGENOMICS, INC., as Parent, NEOGENOMICS LABORATORIES, INC., PATH LABS, LLC, and the other parties...
Credit Agreement • December 31st, 2015 • Neogenomics Inc • Services-testing laboratories • New York

THIS CREDIT AGREEMENT (this “Agreement”), is entered into as of December 30, 2015, by and among the lenders identified on the signature pages hereof (each of such lenders, together with its successors and permitted assigns, is referred to hereinafter as a “Lender”, as that term is hereinafter further defined), WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its successors and assigns in such capacity, “Agent”), NEOGENOMICS, INC., a Nevada corporation (“Parent”), NEOGENOMICS LABORATORIES, INC., a Florida corporation (“NeoGenomics”), PATH LABS, LLC, a Delaware limited liability company (“PathLogic”), and the other parties signatory hereto as “Borrowers” from time to time (such other parties, together with NeoGenomics and PathLogic, are referred to hereinafter each individually as a “Borrower”, and individually and collectively, jointly and se

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!